Zana Brkić

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression

Zana Brkić, Naomi I. Maria, Cornelia G van Helden-Meeuwsen et al. · Annals of the Rheumatic Diseases · 2012 · 300 citations · Full text

Life Sciences, Immunology, Pathology +17

The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis

Zana Brkić, Lenny van Bon, Marta Cossu et al. · Annals of the Rheumatic Diseases · 2015 · 174 citations

Medicine, Immunology, Pathology +17

MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome

Naomi I. Maria, Zana Brkić, Matti Waris et al. · Annals of the Rheumatic Diseases · 2013 · 124 citations · Full text

Life Sciences, Immunology, Pathology +17

Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome

Naomi I. Maria, Eline C. Steenwijk, Arne IJpma et al. · Annals of the Rheumatic Diseases · 2016 · 81 citations

Life Sciences, Immunology, Pathology +17

Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3‐Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon‐Positive Primary Sjögren's Syndrome

Naomi I. Maria, Cornelia G van Helden-Meeuwsen, Zana Brkić et al. · Arthritis & Rheumatology · 2016 · 59 citations · Full text

Life Sciences, Immunology, Pathology +17